DT&CRO Co (XKRX:383930) ROCE % : -42.72% (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is DT&CRO Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. DT&CRO Co's annualized ROCE % for the quarter that ended in Mar. 2024 was -42.72%.

DT&CRO Co ROCE % Historical Data

The historical data trend for DT&CRO Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DT&CRO Co ROCE % Chart

DT&CRO Co Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

ROCE %

53.20

15.86

-37.24

DT&CRO Co Quarterly Data
	Jun21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial					9.81	-17.40	-19.94	-111.04	-42.72

DT&CRO Co ROCE % Calculation

DT&CRO Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-17159.211	/	( ( (64534.991 - 16540.336)	+	(59847.891 - 15695.691) )	/ 2 )
	=	-17159.211	/	( (47994.655	+	44152.2)	/ 2 )
	=	-17159.211	/	46073.4275
	=	-37.24 %

DT&CRO Co's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	-17982.928	/	( ( (59847.891 - 15695.691)	+	(73140.467 - 33100.332) )	/ 2 )
	=	-17982.928	/	( ( 44152.2	+	40040.135 )	/ 2 )
	=	-17982.928	/	42096.1675
	=	-42.72 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

DT&CRO Co (XKRX:383930) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

DT&CRO Co ROCE % Related Terms

Thank you for viewing the detailed overview of DT&CRO Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

DT&CRO Co (XKRX:383930) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DT&CRO Co Ltd (XKRX:383930) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

28, Baengnyeong-ro 20beon-gil, 2nd, 3rd, 4th floor, Na-dong, Cheoin-gu, Gyeonggi-do (Yubang-dong), Yongin-si, KOR, 17042

Website

http://www.dtncro.com

DT&CRO Co Ltd conducts a series of consigned research, from non-clinical GLP toxicity, PK, and efficacy tests required for licensing of pharmaceuticals, chemicals, health functional foods, cosmetics and medical devices, to analysis, bioactivity, clinical trials, and licensing consulting. provided as a service.

DT&CRO Co (XKRX:383930) Headlines

No Headlines